4.7 Article

Nε-Modified lysine containing inhibitors for SIRT1 and SIRT2

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 18, Issue 15, Pages 5616-5625

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2010.06.035

Keywords

Histone deacetylases; NAD(+)-dependent deacetylation; Sirtuin inhibitors

Funding

  1. Graduate School of Drug Discovery, Academy of Finland [127062]
  2. Orion Farmos Research Foundation
  3. Finnish Cultural Foundation
  4. Emil Aaltonen Foundation
  5. Saastamoinen Foundation
  6. Academy of Finland (AKA) [127062, 127062] Funding Source: Academy of Finland (AKA)

Ask authors/readers for more resources

Sirtuins catalyze the NAD(+) dependent deacetylation of N-epsilon-acetyl lysine residues to nicotinamide, O '-acetyl- ADP-ribose (OAADPR) and N-epsilon-deacetylated lysine. Here, an easy-to-synthesize Ac-Ala-Lys-Ala sequence has been used as a probe for the screening of novel N-epsilon-modified lysine containing inhibitors against SIRT1 and SIRT2. N-epsilon-Selenoacetyl and N-epsilon-isothiovaleryl were the most potent moieties found in this study, comparable to the widely studied N-epsilon-thioacetyl group. The N-epsilon-3,3-dimethylacryl and N-epsilon-isovaleryl moieties gave significant inhibition in comparison to the N-epsilon-acetyl group present in the substrates. In addition, the studied N-epsilon-alkanoyl, N-epsilon-alpha,beta-unsaturated carbonyl and N-epsilon-aroyl moieties showed that the acetyl binding pocket can accept rather large groups, but is sensitive to even small changes in electronic and steric properties of the N-epsilon-modification. These results are applicable for further screening of Ne-acetyl analogues. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available